CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 400 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00516776
NCT00516776N/ACompleted

The Innate Immune System and Inflammatory Bowel Disease

Norwegian University of Science and Technology·observational·Posted Aug 15, 2007·Updated Feb 14, 2018

In Brief

An observational study for Ulcerative Colitis and Crohn's Disease. Completed, enrolled 400 participants across 1 site.

Detailed Summary

The study includes individuals with ulcerative colitis, Crohn's disease and healthy controls. The purpose of this study is to examine the innate immune system (IIS) by exposing peripheral blood monocytes to various ligands relevant for stimulation of the IIS and study the immune response. Colonic mucosal samples are examined to find gene expression patterns which may distinguish the two forms of disease from each other and from healthy controls. The hypothesis is that the innate immune system has responses unique for the disease states, and that the diseases may be differentiated by examination of gene expression patterns in mucosal biopsies.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesNorway

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 15, 2007
Enrollment StartJun 1, 2007
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 10.5 yearsPosted 18.9 years ago